📢 Exclusive on Gate Square — #PROVE Creative Contest# is Now Live!
CandyDrop × Succinct (PROVE) — Trade to share 200,000 PROVE 👉 https://www.gate.com/announcements/article/46469
Futures Lucky Draw Challenge: Guaranteed 1 PROVE Airdrop per User 👉 https://www.gate.com/announcements/article/46491
🎁 Endless creativity · Rewards keep coming — Post to share 300 PROVE!
📅 Event PeriodAugust 12, 2025, 04:00 – August 17, 2025, 16:00 UTC
📌 How to Participate
1.Publish original content on Gate Square related to PROVE or the above activities (minimum 100 words; any format: analysis, tutorial, creativ
Johnson & Johnson announced the launch of Evusheld injection in China.
On April 12, Jin10 reported that Johnson & Johnson announced the official launch of its innovative lung cancer treatment drug Ruko (Avelumab injection) in China. Ruko is administered in combination with carboplatin and pemetrexed and is indicated for first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer confirmed to carry epidermal growth factor receptor (EGFR) exon 20 insertion mutations.